Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development Author Name Andrew Davies et al Category Computer science, information & general works Type Journal Tags Chronic lymphocytic leukemia,Diffuse Large B-Cell Lymphoma,Follicular lymphoma,Intravenous,MabThera,Non-Hodgkin lymphoma,Rituxan,Rituximab,Subcutaneous Login to Access Content